1. Biochemistry and Chemical Biology

Prediction and characterization of enzymatic activities guided by sequence similarity and genome neighborhood networks

  1. Suwen Zhao
  2. Ayano Sakai
  3. Xinshuai Zhang
  4. Matthew W Vetting
  5. Ritesh Kumar
  6. Brandan Hillerich
  7. Brian San Francisco
  8. Jose Solbiati
  9. Adam Steves
  10. Shoshana Brown
  11. Eyal Akiva
  12. Alan Barber
  13. Ronald D Seidel
  14. Patricia C Babbitt
  15. Steven C Almo  Is a corresponding author
  16. John A Gerlt  Is a corresponding author
  17. Matthew P Jacobson  Is a corresponding author
  1. University of California, San Francisco, United States
  2. University of Illinois at Urbana-Champaign, United States
  3. Albert Einstein College of Medicine, United States
https://doi.org/10.7554/eLife.03275
Share this article
Cite this article
  1. Suwen Zhao
  2. Ayano Sakai
  3. Xinshuai Zhang
  4. Matthew W Vetting
  5. Ritesh Kumar
  6. Brandan Hillerich
  7. Brian San Francisco
  8. Jose Solbiati
  9. Adam Steves
  10. Shoshana Brown
  11. Eyal Akiva
  12. Alan Barber
  13. Ronald D Seidel
  14. Patricia C Babbitt
  15. Steven C Almo
  16. John A Gerlt
  17. Matthew P Jacobson
(2014)
Prediction and characterization of enzymatic activities guided by sequence similarity and genome neighborhood networks
eLife 3:e03275.
https://doi.org/10.7554/eLife.03275
  2. Download BibTeX
  3. Download .RIS

Abstract

Metabolic pathways in eubacteria and archaea often are encoded by operons and/or gene clusters (genome neighborhoods) that provide important clues for assignment of both enzyme functions and metabolic pathways. We describe a bioinformatic approach (genome neighborhood network; GNN) that enables large scale prediction of the in vitro enzymatic activities and in vivo physiological functions (metabolic pathways) of uncharacterized enzymes in protein families. We demonstrate the utility of the GNN approach by predicting in vitro activities and in vivo functions in the proline racemase superfamily (PRS; InterPro IPR008794). The predictions were verified by measuring in vitro activities for 51 proteins in 12 families in the PRS that represent ~85% of the sequences; in vitro activities of pathway enzymes, carbon/nitrogen source phenotypes, and/or transcriptomic studies confirmed the predicted pathways. The synergistic use of sequence similarity networks3 and GNNs will facilitate the discovery of the components of novel, uncharacterized metabolic pathways in sequenced genomes.

https://doi.org/10.7554/eLife.03275.001

eLife digest

DNA molecules are polymers in which four nucleotides—guanine, adenine, thymine, and cytosine—are arranged along a sugar backbone. The sequence of these four nucleotides along the DNA strand determines the genetic code of the organism, and can be deciphered using various genome sequencing techniques. Microbial genomes are particularly easy to sequence as they contain fewer than several million nucleotides, compared with the 3 billion or so nucleotides that are present in the human genome.

Reading a genome sequence is straight forward, but predicting the physiological functions of the proteins encoded by the genes in the sequence can be challenging. In a process called genome annotation, the function of protein is predicted by comparing the relevant gene to the genes of proteins with known functions. However, microbial genomes and proteins are hugely diverse and over 50% of the microbial genomes that have been sequenced have not yet been related to any physiological function. With thousands of microbial genomes waiting to be deciphered, large scale approaches are needed.

Zhao et al. take advantage of a particular characteristic of microbial genomes. DNA sequences that code for two proteins required for the same task tend to be closer to each other in the genome than two sequences that code for unrelated functions. Operons are an extreme example; an operon is a unit of DNA that contains several genes that are expressed as proteins at the same time.

Zhao et al. have developed a bioinformatic method called the genome neighbourhood network approach to work out the function of proteins based on their position relative to other proteins in the genome. When applied to the proline racemase superfamily (PRS), which contains enzymes with similar sequences that can catalyze three distinct chemical reactions, the new approach was able to assign a function to the majority of proteins in a public database of PRS enzymes, and also revealed new members of the PRS family. Experiments confirmed that the proteins behaved as predicted. The next challenge is to develop the genome neighbourhood network approach so that it can be applied to more complex systems.

https://doi.org/10.7554/eLife.03275.002

Introduction

The explosion in the number of sequenced eubacterial and archaeal genomes provides a challenge for the biological community: >50% of the proteins/enzymes so identified have uncertain or unknown in vitro activities and in vivo physiological functions. Genome context can provide important clues for assignment of functions to individual enzymes and, also, guide the discovery of novel metabolic pathways: pathways often are encoded by operons and/or gene clusters. However, large-scale approaches are required to efficiently mine this information for entire protein/enzyme families (Dehal et al., 2010; Caspi et al., 2012; Markowitz et al., 2012; Franceschini et al., 2013; Overbeek et al., 2014).

In this manuscript, we describe the use of a new bioinformatic strategy, genome neighborhood networks (GNNs), to discover the enzymes, transport systems, and transcriptional regulators that constitute metabolic pathways, thereby facilitating prediction of their individual in vitro activities and combined in vivo metabolic functions. As the first demonstration of its use, we applied this approach to the functionally diverse proline racemase superfamily (PRS) and predicted functions for >85% of its members. The predictions were verified using high-throughput protein expression and purification, in vitro enzyme activity measurements, microbiology (phenotypes and transcriptomics), and X-ray crystallography.

Three enzymatic activities have been described for the PRS: proline racemase (ProR; eubacteria [Stadtman et al., 1957] and eukaryotes [Reina-San-Martín et al., 2000], 4R-hydroxyproline 2-epimerase (4HypE; eubacteria [Adams and Frank, 1980; Goytia et al., 2007; Gavina et al., 2010]), and trans 3-hydroxy-L-proline dehydratase (t3HypD; eukaryotes [Visser et al., 2012] and eubacteria [Watanabe et al., 2014]); these reactions and the pathways in which they participate are shown in Figure 1. The previously characterized ProRs and 4HypEs catalyze racemization/epimerization of the a-carbon in a 1,1-proton transfer mechanism that, in the structurally characterized enzymes, uses two general acidic/basic Cys residues located on opposite faces of the active site (Buschiazzo et al., 2006; Rubinstein and Major, 2009). The syn-dehydration reaction catalyzed by t3HypD requires a general basic catalyst to abstract the proton from the a-carbon; its conjugate acid likely functions as the general acidic catalyst to facilitate departure of the 3-hydroxyl group. Sequence alignment of the functionally characterized t3HypDs and ProRs suggests the presence of a single active site Cys residue in the active sites of the t3HypDs (the second Cys in ProR is replaced by a Thr residue).

Figure 1
Download asset Open asset
The reactions catalyzed by proline racemase (ProR), 4R-hydroxyproline 2-epimerase (4HypE), and trans-3-hydroxy-L-proline dehydratase (t3HypD) and the metabolic pathways in which they participate.

cHyp oxidase, Pyr4H2C deaminase, a-KGSA dehydrogenase, and ?1-Pyr2C reductase belong to the D-amino acid oxidase (DAAO), dihydrodipicolinate synthase (DHDPS), aldehyde dehydrogenase, and ornithine cyclodeaminase (OCD) (or malate/L-lactate dehydrogenase 2 [MLD2]) superfamilies, respectively. Abbreviations: L-Pro: L-proline; D-Pro: D-proline; 5-AV: 5-aminovalerate; t4Hyp: trans-4-hydroxy-L-proline; c4Hyp: cis-4-hydroxy-D-proline; Pyr4H2C: ?1-pyrroline 4-hydroxy 2-carboxylate; a-KGSA: a-ketoglutarate semialdehyde; a-KG: a-ketoglutarate; t3Hyp: trans-3-hyroxy-L-proline; ?2-Pyr2C: ?2-pyrroline 2-carboxylate; ?1-Pyr2C: ?1-pyrroline 2-carboxylate.

https://doi.org/10.7554/eLife.03275.003

Results

Sequence similarity network for the PRS

A sequence similarity network (SSN) (Atkinson et al., 2009) for 2333 unique sequences in the PRS (InterPro family IPR008794; release 43.0) was constructed and displayed at various e-value thresholds (Figure 2). When the network is displayed with an e-value threshold of 10-55 (> ~35% sequence identity is required to draw an edge [line] between nodes [proteins]), the majority of the members of the PRS are located in a single functionally heterogeneous cluster (Figure 2A). As the e-value threshold stringency is increased to 10-110 (sequence identity required to draw an edge is increased to > ~60%), the PRS separates into 28 clusters and 49 singletons (Figure 2B). For analyses of the genome neighborhoods (vide infra), each cluster in the 10-110 network was assigned a unique color and number as shown in Figure 2B (the node colors in Figure 2A depict their association with the clusters in Figure 2B).

Figure 2
Download asset Open asset
Sequence similarity networks (SSNs) for the PRS.

(A) The SSN displayed with an e-value threshold of 10-55 (~35% sequence identity). (B) The SSN displayed with an e-value threshold of 10-110 (~60% sequence identity).

https://doi.org/10.7554/eLife.03275.004

At the e-value threshold of 10-110 (Figure 2B) the nodes for the experimentally characterized functions—ProR (magenta; cluster 7), 4HypE (blue and red; clusters 1 and 2, respectively), and t3HypD (brown; cluster 8)—are located in separate clusters that account for ~30% of the sequences in the PRS. When the e-value threshold is relaxed to 10-55, most of the clusters merge, although the nodes associated with the two previously characterized 4HypE clusters in the 10-110 network remain separated. Sequence alignments predict that the active sites of both characterized 4HypE clusters contain two active site Cys residues. We conclude that these two families of 4HypEs evolved from divergent, but homologous, ancestors.

At the e-value threshold of 10-110 (Figure 2B), the separated clusters are expected to be isofunctional because, from sequence alignments, their active sites are formed from conserved amino acid residues (acid/base catalysts and specificity determining residues). Although many of the clusters are predicted to have the two active site Cys residues found in the structurally characterized ProR (PDB: 1W61) and 4HypE (PDB: 2AZP [Liu et al.]), others are missing one or both of the Cys residues. The previously uncharacterized enzymes with differing residues could either represent new functions or additional examples of evolution of the ProR, 4HypE, and t3HypD functions from divergent, but homologous, ancestors.

GNN for the PRS

We predicted functions for ~80% of the remaining members of the PRS by analyzing the SSN for the proteins (including enzymes, transport systems, and transcriptional regulators) encoded by the genome neighborhoods for ‘all’ members of the PRS (specifically, ± 10 genes relative to the gene encoding each PRS member, the query). A protein in this genome neighborhood SSN, designated the ‘genome neighborhood network’ (GNN), is expected to be functionally related to a query in the PRS if they are located in an operon and/or gene cluster that encodes a metabolic pathway that includes the query. By analyzing many genome neighborhoods simultaneously, e.g., for all members of the PRS, the signals associated with functionally related proteins will be amplified; the signals associated with functionally unrelated genome proximal proteins that occur ‘randomly’ across many species will contribute to the background ‘noise’. We propose that this large-scale approach is more efficient in identifying ‘all’ of the enzymes/transport systems/transcriptional regulators in a conserved metabolic pathway than by a one-genome-at-a-time analysis.

Our approach for visualizing a GNN first assigns a unique query color and number to the members of each cluster in the input SSN that separates the members of the PRS into clusters that are likely to be isofunctional (e-110 in this work). After collecting the genome neighbors, we assign each of them the same color as the color of the query; with this strategy, proteins that are encoded by the same genome neighborhood as the query are easily identified in the GNN because they share the same color as the query. We then perform an all-by-all BLAST on the sequences of the genome neighbors and display the results as an SSN using an e-value threshold of 10-20; this SSN is the GNN. Using this e-value threshold, most of the clusters in the GNN contain the members of distinct protein families and superfamilies (e.g., Pfam families); however, in some cases, divergent families in functionally diverse superfamilies may be found in separate clusters. Genome neighborhood proteins that occur randomly across divergent species and are functionally unrelated to the queries are expected to be located in small clusters with multiple colors, so these can be quickly identified visually and discarded from further analysis. The PRS queries from the input SSN (‘zero sequences’ in collecting the ±10 neighbors) are not displayed in the GNN, except when multiple members of the PRS are proximal on the genome, that is, when one PRS member is in the genome neighborhood of another (vide infra).

The GNN for the PRS (Figure 3A) contains many clusters (protein families). In some clusters, all of the nodes have the same color, that is, they are identified by a single query cluster in the SSN (e.g., the clusters in Figure 3B,C). However, in most clusters the nodes have multiple colors, that is, they are identified by several query clusters in the SSN (e.g., the clusters in Figure 3D–H); this suggests that different query clusters in the SSN have the same in vitro activity and in vivo metabolic function. The clusters in the GNN (Figure 3A) are labeled with their Pfam annotations. The ligand/substrate specificities and/or reaction mechanisms that characterize these families are then used to predict the individual in vitro activities and the shared metabolic pathway identified by a query cluster.

Figure 3
Download asset Open asset
The genome neighborhood network (GGN) for the PRS.

(A) The GNN displayed with an e-value threshold of 10-20. The nodes are colored by the color of query nodes in the SSN (Figure 2A). The clusters are labeled with the UniProtKB/TrEMBL annotations. (B–I) Selected superfamily clusters from the GNN showing node colors. (B) D-proline reductase PrdA. (C) D-proline reductase, PrdB. (D) D-amino acid oxidase (DAAO). (E) Dihydrodipicolinate synthase (DHDPS). (F) Aldehyde dehydrogenase. (G) Ornithine cyclodeaminase (OCD). (H) Malate/L-lactate dehydrogenase 2 (MLD2). (I) Proline racemase.

https://doi.org/10.7554/eLife.03275.005

Retrospective tests of GNN: ProR and 4HypE functions

As a retrospective use of the GNN, the ProR function is encoded by anaerobic eubacteria that ferment L-proline and is represented by the magenta cluster (cluster 7) in the SSN (Figure 2B). The first step in the catabolism of L-proline is racemization to D-proline (by ProR) that is reduced to 2-keto-5-aminopentanoate by D-proline reductase (Kabisch et al., 1999) (by PrdAB; Figure 1). In the GNN, the clusters for the PrdA and PrdB polypeptides in D-proline reductase are uniformly magenta, as expected if the genes encoding ProR and PrdAB are colocalized with the gene encoding ProR (Figure 3B,C). The lack of other colors in the PrdAB clusters in the GNN implies that no other clusters in the SSN have the ProR function.

As a second retrospective example, the 4HypE function has been assigned to members of the blue (cluster 1) and red (cluster 2) clusters in the SSN (Figure 2B). In the GNN, clusters identified by the blue and red clusters include the D-amino acid oxidase (DAAO; Figure 3D) (Watanabe et al., 2012), dihydrodipicolinate synthase (DHDPS; Figure 3E) (Singh and Adams, 1965; Watanabe et al., 2012), and aldehyde dehydrogenase (Figure 3F) (Koo and Adams, 1974; Watanabe et al., 2007) superfamilies as well as components of several types of transport systems. As we and others recently established for organisms that use trans-4-hydroxy-L-proline betaine as sole carbon and nitrogen source (Zhao et al., 2013; Kumar et al., 2014), the catabolic pathway for trans-4-hydroxy-L-proline (t4Hyp) (Figure 1) can be initiated by the epimerization of t4Hyp to cis-4-hydroxy-D-proline (c4Hyp) by 4HypE, followed by reactions catalyzed by c4Hyp oxidase (a member of the DAAO superfamily), c4Hyp imino acid dehydratase/deaminase (a member of the DHDPS superfamily), and a-ketoglutarate semialdehyde dehydrogenase (a member of the aldehyde dehydrogenase superfamily). Thus, the occurrence of blue and red nodes in these three clusters in the GNN is expected.

Discovery of new families of 4HypEs

The DAAO (Figure 3D), DHDPS (Figure 3E), and aldehyde dehydrogenase (Figure 3F) clusters also contain nodes with other colors from the SSN (Figure 2B), including orange (cluster 9), pale green (cluster 11), and teal (cluster 4). Proteins from the orange and pale green clusters were purified and assayed using a library of proline derivatives (Figure 4). As expected, members of the orange and pale green clusters catalyze the 4HypE reaction (Tables 1 and 2). We were unable to purify proteins from the teal cluster (insolubility), so we used the growth phenotypes of the encoding organisms and transcriptomics to identify their in vitro enzymatic activities and in vivo metabolic functions. As predicted from the GNN, Bacillus cereus ATCC14579 (cluster 4, teal) and Streptomyces lividans TK24 (cluster 11, pale green) both utilize t4Hyp as sole carbon source (Table 3); also, the genes encoding the predicted 4HypEs (Table 4) and the proximal genes encoding the predicted c4Hyp oxidases, c4Hyp imino acid dehydratase/deaminases, and a-ketoglutarate semialdehyde dehydrogenases (Table 5) are up-regulated when the encoding organism is grown on t4Hyp as carbon source (Table 4). The purified proteins from the orange groups are promiscuous for the 3HypE reaction (Tables 1 and 2), but their genome neighborhood context identifies their physiological functions as 4HypE.

Figure 4
Download asset Open asset
Library of proline and proline betaine derivatives tested for ESI-MS screening.

These substrates were divided into four groups to avoid mass duplication.

https://doi.org/10.7554/eLife.03275.006
Table 1

Mass spectroscopy screening results in D2O. Hits were observed by mass shift for racemization/epimerization (+1) and dehydration (-17) for reactions performed

https://doi.org/10.7554/eLife.03275.007
Locus tagUniProtL-ProD-Prot4Hypc4Hypt3Hypcis-3-OH-L-Pro
Cluster 1: blue
Pden_4859A3QFI100+1+100
Shew_2363A9AQW900+1+100
Bmul_5265A6WXX700+1+1+1+1
Oant_1111D2QN4400+1+1+1+1
Slin_1478B9JHU600+1+1+1+1
Arad_8151Q8FYS000+1+100
BR1792A1BBM500+ 1+1+1+1
Cluster 2: red
A1S_1325A3M4A900+1+1+1+1
Bamb_3550Q0B9R900+1+1+1+1
BceJ2315_47180B4EHE600+1+1+1+1
BMULJ_04062B3D6W200+1+1+1+1
BTH_II2067Q2T3J400+1+1-170
CV_2826Q7NU7700+1+1+1+1
Csal_2705Q1QU0600+1+100
PFL_1412A5VZY600+1+1+1+1
Pput_1285Q1QBF3+1+1+1+1+1+1
Pcryo_1219A3M4A900+1+1+1+1
XCC2415Q8P83300+1+1+1+1
Bmul_4447A9AL5200+1+1+1+1
ABAYE2385B0VB4400+1+1+1+1
BURPS1106B_1521C5ZMD2+1+1+1+1+1+1
BURPS1710b_A1887Q3JHA900+1+1+1+1
PA1268Q9I47600+1+100
Cluster 3: ligthskyblue
Pden_1184A1B1950000-170
SIAM614_28502A0NXQ90000-170
Atu4684A9CH0100+1+1-170
Avi_7022B9K4G40000-170
Oant_0439A6WW1600+1+100
SM_b20270Q92WR900+1+1-170
BMEI1586Q8YFD600+1+1+1+1
BR0337Q8G2I30000-170
Cluster 5: navy
BC_0905Q81HB100+1+1-170
BCE_0994Q73CS000+1+1-170
BT9727_0799Q6HMS900+1+1-170
Cluster 9: orange
Avi_0518B9JQV300+1+1+1+1
Atu0398A9CKB400+1+1+1+1
RHE_CH00452Q2KD1300+1+1+1+1
Arad_0731B9J8G800+1+1+1+1
Cluster 11: palegreen
Sros_6004D2AV8700+1+100
Cluster 12: olive
Bamb_3769Q0B9500000-170
Bmul_4260A9AKG800+1+1+1+1
Cluster 16: salmon
Csal_2339Q1QV1900+1+100
Maqu_2141A1U2K1000000
Cluster 17: lime
Rsph17029_3164A3PPJ800+1+100
RSP_3519Q3IWG200+1+100
Cluster 18: cyan
SIAM614_28492A0NXQ700+1+100
SADFL11_2813B9R4E300+1+100
SPOA0266Q5LKW300+1+1+1+1
Cluster 22: steelblue
Spea_1705A8H3920000-170
Swoo_2821B1KJ7600+1+1-170
Cluster 61:
Plim_2713D5SQS400+1+1+1+1
Table 2

Kinetic constants for 3/4HypE and t3HypD activities of the screened PRS targets

https://doi.org/10.7554/eLife.03275.008
ClusterLocus tagUniProtFunctionkcat [s-1]Km [mM]kcat/KM[M-1s-1]
1Pden_4859A1BBM54HypE16 ± 225 ± 5630
Shew_2363A3QFI14HypE50 ± 612 ± 34000
Bmul_5265A9AQW93HypE0.34 ± 0.03- a- a
4HypE5.6 ± 0.511 ± 2530
Oant_1111A6WXX73HypE2.4 ± 0.231 ± 777
4HypE89 ± 27.1 ± 0.613000
2BTH_II2067Q2T3J4t3HypD17 ± 326 ± 9660
4HypE40 ± 41.4 ± 0.428000
CV_2826Q7NU773HypE30 ± 0.657 ± 4520
4HypE70 ± 76.8 ± 310000
Pput_1285A5VZY63HypE4.8 ± 0.619 ± 5250
4HypE26 ± 0.70.54 ± 0.0848000
ProR2.8 ± 0.1200 ± 2014
XCC2415Q8P8334HypE28 ± 0.40.67 ± 0.0542000
3HypE1.3 ± 0.0715 ± 386
3Pden_1184A1B195t3HypDnd bnd bnd b
SIAM614_28502A0NXQ9t3HypD15 ± 0.97.8 ± 11900
Atu4684A9CH01t3HypD27 ± 14.2 ± 0.86300
4HypE0.40 ± 0.022.0 ± 0.3200
Avi_7022B9K4G4t3HypD4.3 ± 0.415 ± 3280
Oant_0439A6WW164HypE0.064 ± 0.0021.3 ± 0.249
SM_b20270Q92WR9t3HypD7.9 ± 0.23.8 ± 0.42100
4HypE0.089 ± 0.016.3 ± 214
BMEI1586D0B5563HypE0.085 ± 0.0032.6 ± 0.433
4HypE0.082 ± 0.0054.5 ± 118
BR0337Q8G2I3t3HypD17 ± 25.1 ± 23300
5BCE_0994Q73CS0t3HypDnd bnd bnd b
4HypE1.2 ± 0.033.2 ± 0.3370
BT9727_0799Q6HMS9t3HypD23 ± 57.5 ± 33100
4HypE0.16- a- a
9Avi_0518B9JQV33HypE0.75 ± 0.044.8 ± 0.9160
4HypE1.3 ± 0.075.6 ± 0.5230
Atu0398A9CKB43HypE4.0 ± 0.625 ± 7160
4HypE0.86 ± 0.14.6 ± 2190
RHE_CH00452Q2KD133HypE0.94 ± 0.062.1 ± 0.7450
4HypE1.9 ± 0.082.1 ± 0.3880
11Sros_6004D2AV874HypE14 ± 0.87.8 ± 11800
12Bamb_3769Q0B950t3HypD43 ± 413 ± 33400
Bmul_4260A9AKG83HypE30 ± 118 ± 21700
4HypE1.3 ± 0.042.7 ± 0.3470
16Csal_2339Q1QV194HypE0.070 ± 0.0052.5 ± 0.728
17RSP_3519Q3IWG24HypEnd bnd bnd b
Rsph17029_3164A3PPJ84HypEnd bnd bnd b
18SIAM614_28492A0NXQ74HypE55 ± 33.2 ± 0.517000
SADFL11_2813B9R4E34HypE67 ± 54.1 ± 0.816000
22Spea_1705A8H392t3HypD0.15 ± 0.03- b- b
Swoo_2821B1KJ76t3HypD4.1 ± 0.46.7 ± 2600
  1. a

    The reaction is to slow to measure Km.

  2. b

    The reaction is slow to measure kinetic parameters.

Table 3

Growth phenotypes of bacterial strains when grown on the indicated carbon sources

https://doi.org/10.7554/eLife.03275.009
Organismt4Hypc4Hypt3Hypcis-3-OH-L-prolineL-ProD-glucose
Agrobacterium tumefaciens C58+++++-++++++
Sinorhizobium meliloti 1021+++++-++++++
Labrenzia aggregate IAM12614++++++++++
Pseudomonas aeruginosa PAO1+++++-++++++
Paracoccus denitrificans PD1222++++++++++++++
Rhodobacter sphaeroides 2.4.1++--++++++
Rhodobacter sphaeroides 2.4.1?RSP3519-+--++++++
Bacillus cereus ATCC14579++++++++++++
Roseovarius nubinhibens ISM+++++-++++++
Escherichia coli MG1655----++++++
Streptomyces lividans TK24++++++ND++++++

  1. ‘+++’ represents robust growth (like growth on D-glucose); ++/+ represents slow growth phenotype; ‘--’ represents growth-deficient phenotype; ‘ND’, not determined

Table 4

Transcriptional analysis of PRS members

https://doi.org/10.7554/eLife.03275.010
Organism/Locus Tagt4Hypt3Hyp
Agrobacterium tumefaciens C58
A9CKB412 ± 211 ± 1.5
A9CFV03 ± 1NC
A9CH0164 ± 532 ± 4
Sinorhizobium meliloti 1021
Q92WS15 ± 13 ± 1
Q92WR95.5 ± 1.53.5 ± 1
Labrenzia aggregate IAM12614
A0NXQ722 ± 25 ± 1
A0NXQ912 ± 26 ± 2
Pseudomonas aeruginosa PAO1
Q9I4898 ± 25 ± 1
Q9I47635 ± 37 ± 2
Paracoccus denitrificans PD1222
A1B0W22.0 ± 0.5NC
A1B195NCNC
A1B7P4NCNC
A1BBM54.5 ± 0.5NC
Rhodobacter sphaeroides 2.4.1
Q3IWG210 ± 1NC
Bacillus cereus ATCC14579
Q81HB14 ± 14.5 ± 1
Q81CD722 ± 218 ± 3
Roseovarius nubinhibens ISM
A3SLP212 ± 24+1.5

  1. Fold change in expression for each gene when grown on the indicated carbon source, relative to growth on D-glucose. The identities of the bacterial species and the protein encoded by each gene are indicated. Fold-changes are the averages of five biological replicates with standard deviation (p value < 0.005). NC, no change.

Table 5

Transcriptional analysis of genome neighborhoods

https://doi.org/10.7554/eLife.03275.011
Organism/Locus tagUniProtEnzymeClustert4Hypt3HypL-Pro
Bacillus cereus ATCC 14579
Bc_0905Q81HB1ProRnavy121 ± 1187 ± 10NC
Bc_0906Q81HB0OCD20 ± 314 ± 2NC
Bc_2832Q81CE0ALDH630 ± 39625 ± 5713 ± 2
Bc_2833Q81CD9DHDPS644 ± 61498 ± 376 ± 0.7
Bc_2834Q81CD8ProRhot pink594 ± 27485 ± 298 ± 1
Bc_2835Q81CD7ProRteal408 ± 15567 ± 335 ± 0.5
Bc_2836Q81CD6oxidase623 ± 37633 ± 4210 ± 0.6
Streptomyces lividans TK24
SSPG_01342D6EJL0DAAO81 ± 520 ± 5NC
SSPG_01341D6EJK9oxidase65 ± 96 ± 0.2NC
SSPG_01340D6EJK8oxidase225 ± 2230 ± 33 ± 0.4
SSPG_01339D6EJK7DHDPS136 ± 516 ± 0.2NC
SSPG_01338D6EJK6ProRpalegreen171 ± 823 ± 13 ± 0.2
Agrobacterium tumefaciens C58
Atu_0398A9CKB4ProRorange14 ± 0.416 ± 0.6NC
Atu_3947Q7CTP1DAAONC4 ± 0.2NC
Atu_3948Q7CTP2AlaRNCNCNC
Atu_3949Q7CTP3OCDNCNCNC
Atu_3950Q7CTP4ALDHNCNCNC
Atu_3951A9CFU8LysRNCNCNC
Atu_3952A9CFU9DAAONCNCNC
Atu_3953Q7CFV0ProRblueNCNCNC
Atu_3958Q7CTQ2DAAONCNCNC
Atu_3959Q7CTQ3ALDHNCNCNC
Atu_3960A9CFV4DHDPSNCNCNC
Atu_3961Q7CTQ5GntRNCNCNC
Atu_3985A9CFW8ProCNCNCNC
Atu_4675A9CGZ4DHDPS148 ± 287 ± 7NC
Atu_4676Q7CVK1MLD230 ± 540 ± 7NC
Atu_4678A9CGZ5SBP198 ± 1879 ± 8NC
Atu_4682A9CGZ9DAAO294 ± 1514 ± 3NC
Atu_4684A9CH01ProRlight sky blue116 ± 148 ± 1NC
Atu_4691A9CH042-Hacid_dhNCNCNC

  1. Fold changes in expression for the indicated gene when grown on the indicated carbon source, relative to growth on Dglucose. Fold changes are the averages of three biological replicates with standard deviation. NC, no change.

X-ray structure of a novel 4HypE

The X-ray structure of one of the previously functionally assigned 4HypEs (Uniprot: Q4KGU2; locus tag: PFL_1412; red, cluster 2) was determined in the presence of the substrate, t4Hyp and, also, pyrrole-2-carboxylate (PYC), a stable analogue of the enolate anion intermediate (Figure 5A,B; Table 6). These are the first liganded structures of a 4HypE and the first structure of a PRS with an authentic substrate. These structures corroborate the positioning of the active site Cys/Cys pair (Cys 88, Cys 236) to facilitate substrate epimerization, highlight residues specific to the coordination of the 4-hydroxyl group, and validate the hypothesis that PYC and substrate bind in a similar fashion. In addition, the X-ray structure of one of the newly functionally assigned 4HypEs (Uniprot: B9K4G4; locus tag: Avi_7022; orange, cluster 8) was determined in the presence of its substrate, t4Hyp. The active site contains Ser 93 on one face and Cys 255 on the opposite face (Figure 5C). Thus, despite the conserved ability of this enzyme to catalyze the 4HypE reaction (a two-base 1,1-proton transfer reaction), the Cys–Cys general acid/base pair observed in the structure of Q4KGU2 from the red cluster is not conserved. This observation highlights the structural diversity associated with evolution of function in the PRS. Without the information provided by the GNNs, the 4HypE function would not have been expected.

Figure 5
Download asset Open asset
Structures of members of the PRS.

(A) Structure of Q4KGU2 (locus tag: PFL_1412; cluster 2) with PYC illustrating the utilization of the carboxyl group to bridge the N-terminal amide backbone groups of two opposing a-helices. While In B9K4G4 (D) and B9JQV3 (C) the relative positions of residues that coordinate the prolyl nitrogen (Asp 232, His 90) are conserved His 90 is replaced by a Ser. (B) Structure of Q4KGU2 with t4Hyp illustrating the interactions Q4KGU2 with the 4-hydroxyl group and the relative positions of the two catalytic cysteine residues. (C) Structure of B9JQV3 (locus tag: Avi_0518, cluster 9) with t4Hyp illustrating the interactions of B9JQV3 with the 4-hydroxyl group of t4Hyp and the relative positions of the catalytic Ser (Ser 93, trans?cis) and Cys (Cys 236, cis?trans). (D) Structure of B9K4G4 (Avi_7022, cluster 3) with PYC illustrating the position of the catalytic Ser (Ser 90, dehydration), and the non-catalytic orientation of Thr 256 which replaces the Cys observed in Cys/Cys containing PRS members. In addition, the catalytic Ser (Ser 90) is positioned by hydrogen bonding interactions between the side chain of Asn 93 (shown) and the backbone nitrogen of Asn 93 (not shown). Based on this work, all ProR family members with a catalytic Ser at this position (including B9JQV3, determined here) are proposed to have this motif.

https://doi.org/10.7554/eLife.03275.012
Table 6

Data Collection and Refinement Statisticsa

https://doi.org/10.7554/eLife.03275.013
UNIPROT / CLUSTER / PROTEINA5VZY6 / 2 / Pput_1285A5VZY6 / 2 / Pput_1285Q1QU06 / 2 / Csal_2705Q8P833 / 2 / XCC_2415B3D6W2 / 2 / BMULJ_04062Q4KGU2 / 2 / PFL_1412Q4KGU2 / 2 / PFL_1412A6WW16 / 3 / Oant_0439B9K4G4 / 3 / Avi_7022B9JQV3 / 9 / Avi_0518
OrganismPseudomonas putida F1Pseudomonas putida F1Chromohalobacter salexigens DSM 3043Xanthomonas campestrisBurkholderia multivoransPseudomonas fluorescens Pf-5Pseudomonas fluorescens Pf-5Ochrobacterium anthropiAgrobacterium vitis S4Agrobacterium vitis S4
PDBID4JBD4JD74JCI4JUU4K7X4J9W4J9X4K8L4K7G4LB0
DIFFRACTION DATA STATISTICS
Space GroupI2P212121P212121P212121I4122P21P212121I222P43212P42212
Unit Cell (Å , °)a=45.2 b=54.2 c=142.7a=64.8 b=96.8 c=109.2a=48.1 b=54.4 c=253.0a=54.9 b=108.8 c=116.2a=114.9 b=114.9 c=173.7a=56.2 b=74.6 c=87.1 β=105.5a=64.8 b=96.8 c=109.2a=77.3 b=78.3 c=114.4a=54.9 b=108.8 c=116.2a=178.0 b=178.0 c=49.7
Resolution (Å)1.3 (1.3-1.32)1.5 (1.5-1.58)1.7 (1.7-1.79)1.75 (1.75-1.84)1.75 (1.75-1.84)1.6 (.6-1.69)1.7 (1.7-1.79)1.9 (1.9-2.0)2.0 (2.0-2.1)1.7 (1.7-1.79)
Completeness (%)99.8 (99.6)99.5 (98.9)97.0 (94.0)99.7 (99.4)100.0 (100.0)99.3 (99.5)99.5 (99.0)99.8 (100.0)100 (100)99.9 (99.9)
Redundancy3.6 (3.5)7.3 (7.1)9.3 (7.8)7.3 (7.1)14.3 (13.5)3.6 (3.5)6.7 (6.0)7.2 (7.3)14.1 (13.2)10.4 (7.9)
Mean(I)/sd(I)7.9 (1.4)18.0 (1.1)17.5 (3.3)18.0 (1.1)14.1 (1.1)6.9 (1.7)11.6 (1.5)6.0 (1.3)11.6 (3.3)18.3 (2.7)
Rsym0.062 (0.735)0.067 (0.707)0.073 (0.644)0.074 (0.725)0.130 (0.699)0.093 (0.434)0.088 (0.531)0.09 (0.594)0.17 (0.836)0.078 (0.745)
REFINEMENT STATISTICS
Resolution (Å)1.3 (1.3-1.31)1.5 (1.5-1.52)1.7 (1.7-1.72)1.75 (1.75-1.77)1.75 (1.75-1.78)1.6 (1.6-1.62)1.7 (1.7-1.72)1.9 (1.9-1.97)2.0 (2.0-2.02)1.7 (1.72-1.70)
Unique reflections827491098887212870700585749074077405276748662887548
Rcryst (%)15.8 (30.4)15.9 (22.6)17.1 (23.7)15.2 (21.5)13.8 (19.7)19.7 (28.8)19.4 (23.5)16.8 (17.6)13.6 (19.5)15.8 (22.9)
Rfree (%, 5% of data)18.4 (31.1)17.5 (25.4)20.5 (26.2)18.4 (26.4)15.6 (18.5)23.2 (33.8)22.5 (27.5)20.7 (21.7)16.6 (22.9)19.2 (27.3)
Residues In Model [Expected]A1-A308 [1-308]A(-5)-A308, D(-3)-D308 [1-308]A(-3)-A169, A171-A309 [1-311]A(-2)-A312, B(-2)-B312 [1-312]A(-3)-A310 [1-311]A1-A310, B1-B310 [1-310]A1-310, B1-310 [1-310]A0-A157, A161-A184, A193-A245, A255-280, A289-A332 [1-343]B5-B342, D(-9)-D342 [1-342]A1-A323, A326-A344, B0-B346 [1-347]
Residues / Waters / Atoms total308 / 453 / 3142626 / 752 / 6225620 / 494 / 5780626 / 596 / 5841314 / 463 / 3223620 / 537 / 5301620 / 630 / 5378305 / 191 / 2824690 / 780 / 6761689 / 701 / 6633
Bfactor Protein/Waters/Ligand17.3 / 31.2 / 21.719.3 / 30.5 / 27.924.8 / 33.6 / -23.9 / 35.2 / 37.315.6 / 34.0 / 30.621.1 / 32.2 / 12.922.9 / 34.0 / 16.331.3 / 37.7 / -24.1 / 37.5 / 15.225.1 / 36.2 / 17.9
LigandCitrateSulfate-Phosphate / UNLPhosphate(PYC) Pyrrole 2-carboxylate(t4Hyp) Trans- 4OH-L-Proline-(PYC) Pyrrole 2-carboxylate(t4Hyp) Trans- 4OH-L-Proline / Acetate
RMSD Bond Lengths (Å) / Angles (°)0.008 / 1.2830.009 / 1.3250.011 / 1.3320.010 / 1.260.009 / 1.2680.006 / 1.0790.006 / 1.0930.011 / 1.3490.011 / 1.3110.010 / 1.320
Ramachandran Favored / Outliers (%)98.7 / 0.096.8 / 0.0098.2 / 0.0099.0 / 0.097.7 / 0.098.7 / 0.098.5 / 0.098.3 / 0.098.0 / 0.398.4 / 0.3
Clashscore b2.32 (99th pctl)3.02 (98th pctl)3.74 (97th pctl)4.14 (97th pctl)3.12 (97th pctl)1.59 (99th pctl)1.82 (99th pctl)6.6 (93rd pctl)2.8 (99th pctl)2.2 (99th pctl)
Overall scoreb1.01 (99th pctl)1.29 (95th pctl)1.16 (99th pctl)1.22 (99th pctl)1.16 (99th pctl)0.97 (100th pctl)0.94 (100th pctl)1.36 (98th pctl)1.08 (100th pctl)1.0 (100th pctl)
  1. a

    Data in parenthesis is for the highest resolution bin

  2. b

    Scores are ranked according to structures of similar resolution as formulated in MOLPROBITY

Discovery of novel families of t3HypDs and ?1-Pyr2C reductases

The t3HypD function previously was assigned to eukaryotic members of the PRS (Visser et al., 2012), so their genome neighbors are not represented in the GNN. However, the members of the navy cluster (cluster 5; species of Bacilli) identify several clusters in the GNN, including families of the components of TRAP and ABC transport systems, families of peptidases, and a family in the ornithine cyclodeaminase superfamily (OCDS); several members of the olive cluster (cluster 12) also identify the same OCDS cluster (Figure 3G). Members of the OCDS catalyze NAD(P)+/NAD(P)H-dependent reactions that involve the ketimines obtained by oxidation of a-amino acids (Goodman et al., 2004; Schröder et al., 2004; Gatto et al., 2006); some have been reported to catalyze the reduction of the ketimine of proline (Hallen et al., 2011) (and oxidation of L-proline; Figure 6A). Using purified proteins, we determined that members of both the navy (cluster 5) and olive (cluster 12) clusters in the SSN catalyze the t3HypD reaction (Tables 1 and 2). We also determined that members of the OCDS cluster catalyze the NADPH-dependent reduction of the ketimine of proline to form L-proline (Figure 6A,B). The catabolic pathway for trans-3-hydroxy-L-proline is known to proceed by dehydration, nonenzymatic tautomerization of the dehydration product to the ketimine of proline and, finally, reduction of the ketimine to form L-proline (Figure 1). In the OCDS SSN (Figure 6A), the previously characterized proline ketimine reductases are located in clusters/families distinct from the members of the OCDS identified in our GNN. Thus, assignment of the t3HypD function to the members of navy and olive clusters in the SSN would not have been possible without the synergistic information contained in the GNN.

Figure 6
Download asset Open asset
Sequence divergent members of the ornithine cyclodeaminase superfamily (OCDS) have been the assigned novel pyrroline-2-carboxylate reductase (Pyr2C reductase) function in this work.

(A) The OCDS SSN displayed at the e-value cutoff 10-45 (~35% sequence identity). The Pyr2C reductase function is located in four clusters; these proteins are shown in large colored circles, labeled from 1 to 16, and color-coded by the colors of the PRS query sequences shown in Figure 2B. Proteins representing several previously characterized functions in the OCDS are shown by large diamonds, with borders in hotpink (L-alanine dehydrogenase [Schröder et al., 2004]), brown (ornithine cyclodeaminase [Goodman et al., 2004]), magenta (lysine cyclodeaminase [Gatto et al., 2006]), red (ketamine reductase [Hallen et al., 2011]), green (L-arginine dehydrogenase [Li and Lu, 2009]) and palegreen (tauropine dehydrogenase [Kan-No et al., 2005; Plese et al., 2008]), respectively. Their annotations are shown in italics. The diamonds with blue and olive borders are Pyr2C reductases recently characterized by Watanabe et al. (2014). (B) Kinetics data for the Pyr2C reductase activity for the 16 members of the OCDS shown in panel A using NADPH as the cosubstrate.

https://doi.org/10.7554/eLife.03275.014

Structure of a novel t3HypD

We determined the structure of a t3HypD (B9K4G4) from the light sky blue cluster (cluster 3) in the presence of PYC (Table 6). Instead of the typical PRS Cys/Cys pair, B9K4G4 contains Ser 90 in a similar conformation as was determined for B9JQV3 from the orange cluster (4HypE activity) and Thr 256 on the opposing face (Figure 5D). Thr 256 mimics the conformation of the typical PRS Cys residue but with the side-chain methylene positioned against the anomeric carbon. Again, the assignment of function enabled by the GNNs identifies convergent evolution of function within the PRS.

Discovery of additional families of 4HypEs, t3HypDs, and ?1-Pyr2C reductases

Members of the light sky blue (cluster 3) cluster in the SSN identify the same (super)families identified by both the 4HypE and t3HypD clusters (transport systems, transcriptional regulators, DAAO [Figure 3D], DHDPS [Figure 3E], aldehyde dehydrogenase [Figure 3F], and OCD [Figure 3G]); however, several members of the light sky blue cluster identify a GNN cluster annotated as the malate/L-lactate dehydrogenase 2 superfamily (MLD2; NADH-dependent oxidoreductases) (Muramatsu et al., 2005) (Figure 3H). Using purified members of the PRS, we determined that the light sky blue cluster is functionally heterogeneous (and some members are promiscuous) for the 4HypE and t3HypD functions (Tables 1 and 2). We also determined that members of the MLD2 superfamily in the GNN catalyze the reduction of proline ketimine (Table 7). Thus, the GNN provided essential information for predicting/assigning functions to the members of the light sky blue cluster in the PRS SSN.

Table 7

Kinetic constants for the proline ketimine reductases (members of the malate/Llactate dehydrogenase 2 [MLD2] and ornithine cyclodeaminase [OCD] superfamilies) that are in the genome neighborhoods of members of the PRS

https://doi.org/10.7554/eLife.03275.015
ClusterUniProtLocus tagCofactorkcat [s-1]Km [mM]kcat/KM[M-1s-1]
MLD2_PRS_light skyblue (3)Q7CVK1Atu4676NADPH32 ± 10.33 ± 0.0499000
Q9I492PA1252NADPH1.6 ± 0.050.41 ± 0.063900
MLD2_PRS_Red (2)Q4KGT8PFL_1416NADPH20 ± 0.81.1 ± 0.218000
Q0B9S2Bamb_3547NADPH54 ± 139.4 ± 45700
A9ALD3Bmul_4451NADPH33 ± 27.4 ± 14400
MLD2_PRS_indigo (13)Q4KAT3PFL_3547aNADPH--2300b
OCD_PRS_light skyblue (3)A1B196Pden_1185NADPH260 ± 203.1 ± 0.785000
NADH81 ± 2016 ± 65100
A3S939EE36_06353aNADPH6.8 ± 0.71.0 ± 0.36700
A3SU01NAS141_11281aNADPH39 ± 41.2 ± 0.432000
NADH8.2 ± 473 ± 50110
Q16D96RD1_0323aNADPH15 ± 10.27 ± 0.0756000
NADH3.7 ± 0.411 ± 3320
Q5LLV0SPO3821aNADPH130 ± 203.0 ± 0.943000
NADH--840b
Q3IZJ8RSP_0854aNADPH66 ± 40.43 ± 0.09150000
NADH12c--
OCD_PRS_navy (5)Q81HB0BC_0906NADPH15 ± 10.47 ± 0.131000
NADH19 ± 111 ± 21800
Q73CR9BCE_0995NADPH15 ± 11.1 ± 0.313000
NADH2.1 ± 0.37.6 ± 3270
Q6HMS8BT9727_0800NADPH11 ± 13.4 ± 0.93100
NADH2.1 ± 0.418 ± 6120
Q63FA5BCE33L0803NADPH5.8c--
NADH0.87 ± 0.14.9 ± 2180
OCD_PRS_olive (12)Q0B953Bamb_3766NADPH106 ± 41.6 ± 0.264000
NADH41 ± 67.3 ± 35700
Q2T596BTH_II1457aNADPH73 ± 20.39 ± 0.05190000
NADH203 ± 2332 ± 76400
Q3JFG0BURPS1710b_A2543aNADPH7.8 ± 0.50.64 ± 0.112000
NADH6.0 ± 131 ± 13190
A9AKH1Bmul_4263NADPH25 ± 64 ± 26400
OCD_PRS_blue (1)Q485R8CPS_1455NADPH35 ± 0.81.8 ± 0.220000
NADH--170b
A3QH73Shew_2955aNADPH6.7 ± 0.71.6 ± 0.64300
NADH0.37 ± 0.126 ± 1014
  1. a

    Highly homologous to MLD2 or OCD which are in the gene context of proline racemase.

  2. b

    The enzyme didn’t saturate.

  3. c

    KM is too small (< 0.03mM).

Discussion

Although in most cases interpretations of the functional relationships of the clusters in the GNN with those in the query SSN are straightforward, complications can arise. For example, in several species, two members of the PRS are encoded by proximal genes, that is, a 4HypE and a t3HypD; these species can utilize both t4Hyp and trans-3-hydroxy-L-proline as carbon and nitrogen sources. Thus, the GNN contains a cluster for the PRS (right-hand cluster in the top row [when used as query, each PRS finds the adjacent PRS; Figure 3I]). For these species, clusters in the GNN are a composite of two genome contexts, that is, the proteins/enzymes that participate in both catabolic pathways. These situations can be deconvoluted by coloring the nodes identified by two queries with the colors for both query clusters in the GNN. With the genome contexts/metabolic pathways identified for ‘genome-isolated’ 4HypEs and t3HypDs, this complication is easy to identify and understand.

The GNN also is useful to assess the physiological importance of in vitro promiscuity. Several of the purified proteins catalyze both the 4HypE and t3HypD reactions (Tables 1 and 2). Some of these promiscuous proteins identify both the OCD or MLD2 superfamilies (predicting the t3HypD pathway) and the DAAO, DHDPS, and aldehyde dehydrogenase superfamilies (predicting the 4HypE pathway) in their genome neighborhoods (Figure 7). In these cases, we conclude that the in vitro promiscuity is not an ‘artifact’ but is physiologically significant.

Figure 7
Download asset Open asset
Mapping members of GNN clusters back to the SSN for the PRS.

(A) SSN for the PRS with cluster numbers. (B) D-amino acid oxidase (DAAO). (C) Dihydrodipicolinate synthase (DHDPS). (D) Aldehyde dehydrogenase. (E) Ornithine cyclodeaminase (OCD). (F) Malate/L-lactate dehydrogenase 2 (MLD2). (G) The color scheme for B–F.

https://doi.org/10.7554/eLife.03275.016

As established in this study, the majority of the members of the PRS catalyze only the three previously characterized (known) reactions (Figure 1). As a result, we were able to use the GNN without any additional information to correctly predict functions for all of the highly populated clusters/families (>85% of the members; Figure 8). Because of this simplicity, the PRS provides a lucid illustration of the strategy by which a query SSN and its GNN can be used to predict and assign enzymatic functions.

Figure 8
Download asset Open asset
Experimentally characterized enzymes reported by Swiss-Prot (small colored circles) and newly characterized in this work (large colored circles).

Colors match the color scheme in Figure 2B.

https://doi.org/10.7554/eLife.03275.017

However, large-scale prediction and assignment of function to members of many functionally diverse (super)families will be more complicated than that described for the PRS and require information from complementary experimental and computational approaches. The use of GNNs is restricted to those enzymes that are encoded by proximal operons and/or gene clusters in eubacteria and archaea. For Escherichia coli K-12, 60% of the genes are located in polycistronic transcriptional units that may provide linked functional information that can be used to identify pathways; 40% are located in monocistronic transcriptional units (http://regulondb.ccg.unam.mx/menu/tools/regulondb_overviews/chart_form.jsp). Thus, genome neighborhood context is not a general solution to infer functions for many proteins/enzymes of unknown function encoded eubacterial and archaeal genomes. Even for those proteins encoded by polycistronic transcriptional units, complete metabolic pathways may be encoded by multiple transcriptional units (mono- and/or polycistronic) that are not genome proximal; these pathways and their component enzymes and ligand binding proteins (solute binding proteins for transport systems and transcriptional regulators) may be recognized by regulon analyses that identify conserved binding sites for transcriptional regulators (Ravcheev et al., 2013; Rodionov et al., 2013).

To the extent that genome neighborhoods and/or regulons allow the identification of the components of unknown/novel metabolic pathways, the locations of these proteins/enzymes in the SSNs for their (super)families will provide restrictions on their ligand/substrate specificities and/or reaction mechanisms (Atkinson et al., 2009). Also, as we recently demonstrated (Zhao et al., 2013), in silico (virtual) docking of ligand libraries to multiple binding proteins and enzymes in an unknown metabolic pathway (pathway docking) is a powerful approach to enhance the reliability of docking to predict novel ligand/substrate specificities and identify novel metabolic pathways

Irrespective of the many complications associated with assignment of function to unknown proteins/enzymes, we conclude that GNNs provide a novel approach for large-scale analysis and visualization of genome neighborhood context in enzyme (super)families. We are continuing to improve the use of GNNs as well as regulon analyses and pathway docking to facilitate the discovery of novel enzymes and the metabolic pathways in which they function.

Materials and methods

Sequence similarity networks (SSN)

Request a detailed protocol

The SSNs for the PRS (Figure 2) and the OCDS (Figure 5A) were created using Pythoscape v1.0 (Barber and Babbit, 2012) that is available for download from http://www.rbvi.ucsf.edu/trac/Pythoscape The input sequences were downloaded from the InterPro webpages of PRS and OCDS: http://www.ebi.ac.uk/interpro/entry/IPR008794, http://www.ebi.ac.uk/interpro/entry/IPR003462, respectively. Cytoscape v2.8 (Smoot et al., 2011) is used for visualization and analysis of the SSN.

Genome neighborhood network (GNN)

Request a detailed protocol

The GNN for the PRS (Figure 3) was also created using Pythoscape v1.0 (Barber and Babbit, 2012). At an e-value cutoff 10-110, each cluster in the SSN was assigned a unique cluster number and color, which are used for labeling and coloring genome context sequences. Genome context sequences were collected from the ±10 gene range of each PRS member and used as the input sequences for making the GNN using the procedure for generating a SSN.

Protein production

Request a detailed protocol

Genes for members of the PRS that are encoded by the genomic DNAs in the Macromolecular Therapeutics Development Facility at the Albert Einstein College of Medicine were cloned into pNIC28-BSA4-based expression vectors as previously described (Sauder et al., 2008).

Protein expression

Request a detailed protocol

The pNIC28-BSA4-based expression plasmids were transformed into Escherichia coli BL21(DE3) containing the pRIL plasmid (Stratagene, Agilent Technologies, Inc., Wilmington, DE) and used to inoculate 20 ml 2xYT cultures containing 50 µg/ml kanamycin and 34 µg/ml chloramphenicol. Cultures were allowed to grow overnight at 37°C in a shaking incubator; these were used to inoculate 2 L of PASM-5052 auto-induction medium (Studier). The cultures were placed in a LEX48 airlift fermenter and incubated at 37°C for 5 hr and then at 22°C overnight (16–20 hr). The cells were collected by centrifugation at 6000×g for 10 min and stored at -80°C.

Purification of proteins

Request a detailed protocol

Cells were resuspended in Lysis Buffer (20 mM HEPES, pH 7.5, containing 20 mM imidazole, 500 mM NaCl, and 5% glycerol) and lysed by sonication. Lysates were clarified by centrifugation at 35,000×g for 45 min. The clarified lysates were loaded on a 1-ml His60 Ni-NTA column (Clontech) using an AKTAxpress FPLC (GE Healthcare). The columns were washed with 10 column volumes of Lysis Buffer and eluted with buffer containing 20 mM HEPES, pH 7.5, containing 500 mM NaCl, 500 mM imidazole, and 5% glycerol. The purified proteins were loaded onto a HiLoad S200 16/60 PR gel filtration column equilibrated with a buffer containing 20 mM HEPES, pH 7.5, 150 mM NaCl, 5% glycerol, and 5 mM DTT. The purities of the proteins were analyzed by SDS-PAGE. The proteins were snap frozen in liquid N2 and stored at -80°C.

Crystallization

Request a detailed protocol

Proteins were screened for crystallization conditions using commercially available screens (MCSG 1, 2, and 4 [Microlytic, Woburn MA] and MIDAS [Molecular Dimensions, Altamonte Springs FL]) using sitting drop vapor diffusion 96-well INTELLIPLATES (Art Robbins Instruments, Sunnyvale CA), a PHOENIX crystallization robot (Art Robbins Instruments), and stored and monitored in a Rock Imager 1000 (Formulatrix, Waltham MA) plate hotel. Protein (1 µl) was combined with an equivalent volume of precipitant and equilibrated against a 70 µl reservoir of the same precipitant at room temperature (~292 K).

A5VZY6, (27.9 mg/mL, 15 mM HEPES, pH 7.5, containing 150 mM NaCl, and 5 mM DTT) was crystallized in 0.1 M sodium acetate, pH 4.6, containing 1.5 M LiSO4; the crystals grew as rectangular bricks over a 1-week period (SPG-P212121). For the cryoprotectant, the LiSO4 concentration was increased to 1.8M.

A5VZY6 was also crystallized (27.9 mg/ml, 15 mM HEPES, pH 7.5, containing 150 mM NaCl, and 5 mM DTT) in 0.2 M diammonium hydrogen citrate pH 5.0, containing 20% (wt/vol) PEG 3350; the crystals grew as wedges over a 1-week period. The cryoprotectant contained 20% glycerol.

Q1QU06 (21.1 mg/ml, 15 mM HEPES, pH 7.5, containing 150 mM NaCl, and 5 mM DTT) was crystallized in 0.2 M di-ammonium hydrogen citrate, pH 5.0, containing 20% (wt/vol) PEG 3350; the crystals grew as plates over 2–3 days. The cryoprotectant contained 20% glycerol.

XCC2415 (29.3 mg/ml, 15 mM HEPES, pH 7.5, containing 150 mM NaCl, and 5 mM DTT) was crystallized in 0.1 M HEPES, pH 7.5, containing 0.8 M sodium phosphate and 0.8 M potassium phosphate and grew as thin rods over 2–3 days. The cryoprotectant contained 20% glycerol.

B3D6W2 (21.8 mg/ml, 15 mM HEPES, pH 7.5, containing 150 mM NaCl, and 5 mM DTT) was crystallized in 0.1 M phosphate-citrate, pH 4.2, containing 1.6 M NaH2PO4, and 0.4 M K2HPO4 and grew as large rods over 2 weeks. The cryoprotectant contained 20% glycerol.

Q4KGU2 (25.7 mg/ml, 15 mM HEPES, pH 7.5, containing 150 mM NaCl, and 5 mM DTT) was crystallized in 0.2 M ammonium acetate, 0.1 M trisodium citrate, pH 5.6, containing 14% PEG4000, 5% glycerol, and either 20 mM PYC or 50 mM t4Hyp and grew as thick plates over 2–3 days. The cryoprotectant contained 20% glycerol.

For A6WW16, B9K4G4, and B9JQV3, TEV protease (Tropea et al., 2009) was added at a 1/80 ratio prior to crystallization setup. The samples were incubated on ice for 2 hr, and the buffer was exchanged with 15 mM HEPES, pH 7.5, containing 5 mM DTT by dilution and centrifugal filtration. The extent of TEV cleavage was not measured.

A6WW16 (17.3 mg/ml, 15 mM HEPES, pH 7.5, containing 5 mM DTT) was crystallized in 0.2 M sodium nitrate and 20% PEG3350 and grew as leaf petals over 2 to 3 weeks. The cryoprotectant contained 20% glycerol.

B9K4G4, (17.1 mg/ml, 15 mM HEPES, pH 7.5, containing 5 mM DTT) was crystallized in 0.1 M sodium acetate, pH 4.6, containing 1 M ammonium citrate and 25 mM pyrrole 2-carboxylate. Crystals grew from an initial precipitate as multifaceted crystals over a month. The cryoprotectant contained 20% glycerol.

B9JQV3 (30.0 mg/ml, 15 mM HEPES, pH 7.5, containing 5 mM DTT) was crystallized in 0.1 M sodium acetate, containing 25% Peg4000, 8% 2-propanol, and 200 mM t4Hyp and grew as tetragonal rods over 2–3 days. The cryoprotectant contained 20% 2-propanol.

Structure determination

Request a detailed protocol

Diffraction data were collected on beamline 31-ID (LRL-CAT, Advanced Photon Source, Argonne National Laboratory, IL) from single crystals at 100 K and a wavelength of 0.9793 Å. Data were integrated using MOSFLM (Battye et al., 2011) and scaled in SCALA (Evans, 2006).

Suitable molecular replacement models existed for all of the protein targets of this study. These included, 2AZP, a putative 4HypE (from cluster 2) determined unliganded by the Midwest Center for Structural Genomics, and 1TM0 (Forouhar et al., 2007), a putative t3HypD (cluster 3, also similar to cluster 9) with an unliganded and disordered active site, determined by the Northeast Structural Genomics Consortium. Molecular replacement computations were performed in AMORE (Navaza, 1994) utilizing the structure that exhibited the greatest homology to the target. If this was unsuccessful, either due to the particular issues with the space group, asymmetric unit composition, or a different orientation of the two domains, molecular replacement was performed with each of the domains separately within PHENIX (Adams et al., 2004; Zwart et al., 2008).

Iterative cycles of manual rebuilding within COOT (Emsley and Cowtan, 2004) and refinement within PHENIX were performed until the entire sequence was modeled. Inclusion of ligands, TLS (translation/libration/screw) refinement (domains chosen automatically within PHENIX) (Winn et al., 2001; Painter and Merritt, 2006) and editing of the solvent structure were performed in the final refinement cycles.

With one exception, the entire sequences of all of the targets could be modeled, except for a small number of residues at the N- or C-termini. The one outlier was A6WW16 that had several disordered regions around the active site similar to the previously determined structure from this cluster (1TM0, cluster 3, light sky blue). Due to the relatively weak binding of the proline racemase family members for their substrates, inhibitors and substrates were included at high concentrations (25–200 mM). Even at these concentrations, several structures were determined from cluster 2 that bound anionic ligands (phosphate, citrate, etc) from the crystallization medium rather than the co-crystallized ligand, and the degree of domain closure about that ligand varied. For all of the structures liganded with either PYC or t4Hyp, the structures are determined in a closed state with Ca–Ca distances of 7–8 Å for the opposing active site catalytic Cys–Cys (cluster 2, red), Ser–Thr (cluster 3, light sky blue) or Ser–Cys dyad (cluster 9, orange). In the case of Q4KGU2, the ligand was t4Hyp state based on the electron density. In contrast, for B9JQV3, the density for the ligand had significant planer character, suggesting a mixture of t4Hyp and c4Hyp.

ESI-MS screening of ProR, 4HypE, and t3HypD activities

Request a detailed protocol

Enzyme activity was screened by the mass change resulting from racemization /epimerization (+1 peak shift) and/or dehydration (-17 peak shift) for reactions in D2O. Each enzyme (1 µM) was incubated with substrate libraries (Table 1) containing proline and proline betaine derivatives (0.1 mM each) along with 20 mM ammonium bicarbonate in D2O at a final volume of 200 µl at 30°C for 16 hr. 50 µl of the reaction mixture was aliquoted and dried with an Eppendorf vacufuge concentrator. The residue was suspended in 10 µl of H2O, and 5 µl of the solution was mixed with the 5 µl of 50% methanol containing 0.4% (vol/vol) formic acid. A 10 µl sample was analyzed for ESI-MS.

1H NMR assay to confirm PRS reactions

Request a detailed protocol

If a change in mass was observed in the ESI-MS screening assays, a 1H NMR assay was performed to determine the product. Each reaction mixture contained 1 µM enzyme, 10 mM substrate, and 25 mM sodium phosphate buffer, pD 8, in a total volume of 800 µl D2O. The mixture was incubated at 30°C for 16 hr before acquisition of the 500 MHz (Hunter et al., 2012) H NMR spectrum (Figure 9).

Figure 9
Download asset Open asset
Demonstration of the 4HypE, 3HypE, and t3HypD reactions by 1H NMR.

(A) 1H NMR spectra of the 4Hyp substrate mixture in 25 mM Na+-phosphate buffer, pD 8, in D2O (top) and 4Hyp mixture with A3QFI1 (cluster 1, blue) showing 4Hyp epimerization (bottom). The red arrow indicates the proton at C2 for epimerization. The enzyme was stored in glycerol, so the spectra show resonances for glycerol between 3.4 and 3.7 ppm. (B) 1H NMR spectra of the t3Hyp substrate mixture in 25 mM Na+-phosphate buffer, pD 8, in D2O (top), t3Hyp mixture with D0B556 (cluster 3, light sky blue) showing 3Hyp epimerization (middle), and t3Hyp mixture with B9K4G4 (cluster 3, light sky blue) showing t3Hyp dehydration (bottom). The red arrow indicates the proton at C2 for epimerization; the green arrow indicates the proton at C3 for dehydration.

https://doi.org/10.7554/eLife.03275.018

Polarimetric assay to determine PRS kinetics

Request a detailed protocol

The enzyme activity was measured in a Jasco P-1010 polarimeter with a Hg 405-nm filter at 25°C by quantitating the change in optical rotation. The assay mixture contained 1 mM dithiothreitol (DTT) and 50 mM Na+-phosphate buffer, pH 8.0.

UV spectrophotometric assay for ?1-Pyr2C reductase activity

Request a detailed protocol

?1-Pyr2C reductase assays were performed by measuring the decrease in the absorbance of NAD(P)H at 340 nm at 25°C with a Cary 300 Bio UV-Visible spectrophotometer (Varian). The reaction mixture (300 µl) contained variable concentrations of Pyr2C, 50 mM Tris–HCl buffer, pH 7.6, 0.16 mM NAD(P)H, and enzyme.

1H NMR assay for ?1-Pyr2C reductase activity

Request a detailed protocol

The reaction mixture contained 10 mM ?1-Pyr2C, 1 µM enzyme, 0.16 mM NADPH, 25 mM phosphate-Na buffer, pD 8.0, 1 U/ml alcohol dehydrogenase (NADP+-dependent from Thermoanaerobium brockii, Sigma) and 80 µl isopropanol in a total volume of 800 µl of D2O; the reaction was incubated at 30°C for 16 hr. The solvent was removed by lyophilization, 800 µl of D2O was added, and the 1H NMR spectrum was recorded. Representative spectra are shown in Figure 10.

Figure 10
Download asset Open asset
Representative 1H NMR spectra for ?1-pyrroline-2-carboxylate (?1-Pyr2C) reductase activity.

(A) 1H NMR spectrum of ?1-Pyr2C substrate in sodium phosphate, pD 8.0, in D2O. (B) 1H NMR spectrum of Q7CVK1 (locus tag: Atu4676) incubated with ?1-Pyr2C, NADPH, and the cofactor regeneration system of alcohol dehydrogenase (NADP+-dependent) and isopropanol in sodium phosphate, pD 8.0 in D2O. (C) 1H NMR spectrum of L-proline in 25 mM sodium phosphate, pD 8.0, in D2O.

https://doi.org/10.7554/eLife.03275.019

Bacterial strains and growth conditions

Request a detailed protocol

Bacterial strains are listed in Table 8. All strains were grown at 30°C with shaking at 225 rpm and were routinely cultured in Tryptic Soy Broth (Difco), supplemented with 30 g L-1 sea salts (Sigma-Aldrich) for Labrenzia aggregata IAM12614 and Roseovarius nubinhibens ISM.

Table 8

Strains used in this study

https://doi.org/10.7554/eLife.03275.020
Organism
Agrobacterium tumefaciens C58
Sinorhizobium meliloti 1021
Labrenzia aggregata IAM12614
Pseudomonas aeruginosa PAO1
Paracoccus denitrificans PD1222
Rhodobacter sphaeroides 2.4.1
Rhodobacter sphaeroides 2.4.1?RSP3519
Bacillus cereus ATCC14579
Roseovarius nubinhibens ISM
Escherichia coli MG1655
Streptomyces lividans TK24

For gene expression analyses and carbon utilization studies, strains were cultured in the following defined media:

Agrobacterium tumefaciens C58 was cultured in M9 minimal medium (per liter: 12.8 g Na2HPO4.7H2O, 3.0 g KH2PO4, 0.5 g NaCl, 1.0 g NH4Cl); B. cereus ATCC 14579 was cultured in a modified Spizizen's minimal medium (Spizizen., 1958) (per liter: 2.0 g (NH4)2SO4, 11.0 g K2HPO4, 6.0 g KH2PO4, 1.0 g sodium citrate.2H2O).

Streptomyces lividans TK24 was cultured in a modified minimal medium of Hopwood (Hopwood., 1967) (per liter: 1.0 g (NH4)2SO4, 0.5 g K2HPO4, 0.005 g FeSO4.7H2O). M9 minimal medium, and Spizizen's minimal medium were supplemented with the following trace metals (per liter: 0.003 mg CuSO4.5H2O, 0.025 mg H3BO3, 0.007 mg CoCl2.6H2O, 0.016 mg MnCl2.4H2O, 0.003 mg ZnSO4.7H2O, 0.3 mg FeSO4.7H2O). The minimal medium of Hopwood was supplemented with the following trace metals (per liter: 0.08 mg ZnCl2, 0.4 mg FeCl3.6H2O, 0.02 mg CuCl2.2H2O, 0.02 mg MnCl2.4H2O, 0.02 mg Na2B4O7.10H2O, 0.02 mg (NH4)6Mo7O24.4H2O).

All other strains were grown in the following defined medium (per liter: 17.0 g K2HPO4, 2.5 g (NH4)2SO4, 2.0 g NaCl) supplemented with the following trace metals (0.3 mg FeSO4.7H2O, 0.003 mg ZnSO4.7H2O, 0.003 mg CuSO4.5H2O, 0.025 mg H3BO3), supplemented with 30 g L-1 sea salts (Sigma-Aldrich) for L. aggregata IAM12614 and R. nubinhibens ISM. All of the above defined media were additionally supplemented with 1 mM MgSO4, 100 µM CaCl2, and vitamins (33 µM thiamine, 41 µM biotin, 10 nM nicotinic acid). 20 mM of one of the following served as the sole source of carbon: D-glucose (Thermo Fisher), t3Hyp (BOC Sciences), c3Hyp (Chem Impex Int’l), t4Hyp (Bachem), c4Hyp (Sigma-Aldrich), or L-proline (CalBiochem).

Plasmid construction for gene disruption

Request a detailed protocol

RSP3519 was amplified from Rhodobacter sphaeroides 2.4.1 genomic DNA using Pfu DNA polymerase (Thermo) with primers RSP3519F and RSP3519R (Table 9). The resulting PCR product was inserted into the pGEM T Easy vector (Promega) to generate plasmid pRK_RSP3519-1. pRK_RSP3519-1 was digested with SmaI and ligated to a 900 bp blunt-ended chloramphenicol resistance cassette to generate pRK_RSP3519-2. pRK_RSP3519-2 was then used as the template in a PCR with primers RSP3519F and RSP3519R. The resulting product was digested with EcoRI and ligated into pSUP202 to give the plasmid used for gene disruption: pRK_RSP3519-3. To disrupt RSP3519, pRK_RSP3519-3 was electroporated into R. sphaeroides 2.4.1, and double crossover chromosomal gene disruptions were selected by resistance to chloramphenicol and sensitivity to ampicillin (Matsson et al., 1998).

Table 9

Oligonucleotide primers used for construction of the RS3519 knock-out in Rhodobacter sphaeroides 2.4.1

https://doi.org/10.7554/eLife.03275.021
OligoSequence (5'–3')
RS3519F.KOCATATGATGCGCGTTCAGGACGTGTATAACG
RS3519R.KOGCTGAGCTCAGAGGACGAGGAAGCCCGCGTCC

Cell preparation for gene expression analysis

Request a detailed protocol

Starter cultures were initiated from a single colony and grown in the appropriate rich medium overnight. This culture was used to inoculate the appropriate minimal medium (1% inoculum) supplemented with 20 mM D-glucose; the cultures were grown until OD600 0.3–0.5. The cells were pelleted by centrifugation (4750×g for 5 min at 4°C), washed once, and resuspended in minimal medium with no carbon source. For gene expression analysis of individual PRS genes, cultures were divided into two equal volumes, 20 mM D-glucose was added to one volume and 20 mM trans-4-hydroxy-L-proline or trans-3-L-hydroxy proline was added to the other, and cultures were grown for three additional hr prior to cell harvest.

For evaluation of whole genome neighbourhoods of select PRS targets (orange, navy, hotpink, pale green, blue, and sky blue clusters) in A. tumefaciens C58, B. cereus ATCC 14579, and S. lividans TK24, cultures were divided into four equal volumes, supplemented with D-glucose, trans-4-hydroxy-L-proline, trans-3-hydroxy-L-proline, or L-proline to a final concentration of 20 mM, and grown until OD600 0.8–1.0. At the time of cell harvest, one volume of RNAprotect Bacteria Reagent (Qiagen) was added to two volumes of each culture. Samples were mixed by vortexing for 10 s and then incubated for 5 min at room temperature. Cells were pelleted by centrifugation (4750×g for 5 min at 4°C), the supernatant was decanted, and cell pellets were stored at -80°C until further use.

RNA isolation

Request a detailed protocol

RNA isolation was performed in an RNAse-free environment at room temperature using the RNeasy Mini Kit (Qiagen) per the manufacturer's instructions. For B. cereus ATCC 14579 and S. lividans TK24, cells were initially disrupted using a modified bead-beating procedure: cells were resuspended in 400 µl Soil Pro Lysis Buffer (MP Bio), transferred to Lysis Matrix E tubes (MP Bio), and agitated horizontally on a Vortex Mixer (Fisher) with Vortex Adapter (Ambion) for 10 min at speed 10. Beads and cellular debris were pelleted by centrifugation at 16,000 × g for 5 min. 200 µl of the supernatant was used for subsequent RNA isolation. Cell pellets for all other organisms were disrupted according to the ‘Enzymatic Lysis Protocol’ in the RNAprotect Bacteria Reagent Handbook (Qiagen); lysozyme (Thermo-Pierce) was used at 15 mg ml-1. RNA concentrations were determined by absorption at 260 nm using the Nanodrop 2000 (Thermo) and absorption ratios A260/A280 and A260/A230 were used to assess sample integrity and purity. Isolated RNA was stored at -80°C until further use.

Reverse transcription and quantitative real-time PCR

Request a detailed protocol

Reverse transcription (RT) PCRs for A. tumefaciens C58 and B. cereus ATCC 14579 were performed with 300 ng of total isolated RNA using the ProtoScript First Strand cDNA Synthesis Kit (NEB) as per the manufacturer's instructions. For S. lividans TK24 RT-PCRs were performed with 300 ng of total RNA using the Transcriptor First Strand cDNA Synthesis Kit (Roche), with 2.5% DMSO added to relieve secondary structures. All other RT-PCRs were performed with 1 µg of total RNA using the RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas).

Primers for quantitative real-time (qRT) PCR for A. tumefaciens C58 and B. cereus ATCC 14579 gene targets were designed using the Primer3 primer tool; amplicons were 150–200 bps in length; primers for all other qRT-PCRS were designed using the Universal ProbeLibrary System (Roche); amplicons were 66–110 bps in length Primer sequences are provided in Tables 10 and 11. Primers were 18–27 nucleotides in length and had a theoretical Tm of 55–60°C. Primer efficiency was determined to be at least 90% for each primer pair.

Table 10

qRT-PCR primers for transcriptional analysis of individual proline racemase superfamily members

https://doi.org/10.7554/eLife.03275.022
OligoSequence (5'–3')
Atu16s-FGACACGGCCCAAACTCCTAC
Atu16s-RGGGCTTCTTCTCCGACTACC
Atu0398-FTCACCATTGAGAAGGCCAAT
Atu0398-RGGTTGACGAGGTCCTTCAGA
Atu3953-FCAGCTTCAGTGGCATCAGG
Atu3953-RGTGTTGTGCCCAATGATCC
Atu4684-FGAAGAGGCGCATGAGATTG
Atu4684-RCGAAACCCAAAGCCTTGTT
Bc16s-FCTCGTGTCGTGAGATGTTGG
Bc16s-RTGTGTAGCCCAGGTCATAAGG
Bc0905-FCTTCGCTGACGGACAAGTAGA
Bc0905-RTGTACCGCTGTTACGGACAA
Bc2835-FAACAGACCCGTGTCATCCTG
Bc2835-RACTAAGCCAGCCGGTGTATCT
La16s-FTGGTGGGGTAAAGGCCTAC
La16s-RTGGCTGATCATCCTCTCAGAC
La28492-FTGTTGAAGACGAGGCCAAG
La28492-RAAAAGCCGAGCTGTTCGTT
La28502-FCGCGTAATCGACAGCCATA
La28502-RGGCACAGAAATCGAGATGCT
Rs16s-FACACTGGGACTGAGACACGG
Rs16s-RTACACTCGGAATTCCACTCA
Rs3519-FAGGACATCGCCTTCGAACT
Rs3519-RCGATGATGCCGAAATAGTTG
Pa16s-FTCACACTGGAACTGAGACACG
Pa16s-RATCAGGCTTTCGCCCATT
Pa1255-FCCACCCTCTGGGAACAGTC
Pa1255-RTCGTTGAGGACGAAGTTGC
Pa1268-FAACAGTGGCTACCTCGGCA
Pa1268-RTCGCCGACCGGTGTCTCGAT
Rn16s-FATCTGTGTGGGCGCGATT
Rn16s-RGTGAGCGCATTGGTGGTCT
Rn08250-FTATGGCGGCGACAGTTTC
Rn08250-RGACGGCTCGAGCGTAAAC
Pd16s-FGACTGAGACACGGCCCAGA
Pd16s-RTCACCTCTACACTCGGAAT
Pd1045-FTCGGACTACTATGTGCCGATG
Pd1045-RCCTGATCGAGGCCAAAGAC
Pd1184-FGCAATTTCGTGTTGAACGAG
Pd1184-RCATGATGATCCAGCCCATCT
Pd3467-FCTTCGCAGCCCTGTTCAT
Pd3467-RGACCAGCCCTTCCTCGAT
Pd4859-FGGCAAGGTGGACATCGAATA
Pd4859-RCCTCGGGGTAAAGGAAGC
Sm16s-FCGTGGGGAGCAAACAGGATT
Sm16s-RCTAAGGGCGAGGGTTGCGCTC
Sm20268-FCTGGCAAGGTGGACATCAC
Sm20268-RGTAAGGCGCACTTCCTCAA
Sm20270-FCGCCATGTCAATCTCCTGGT
Sm20270-RGGCAGCATCCACGATCACGA
Table 11

qRT-PCR primers for transcriptional analysis of genome neighborhoods

https://doi.org/10.7554/eLife.03275.023
PrimerSequence (5'–3')
Sliv-Sco16srRNA-FCCGTACAATGAGCTGCGATA
Sliv-Sco16srRNA-RGAACTGAGACCGGCTTTTTG
Sliv-Sco6289-FGACCCTGAAGGTCGTCGTC
Sliv-Sco6289-RGGTGACCGTGACGTCCAT
Sliv-Sco6290-FGTCTTCTGCGGCATCGG
Sliv-Sco6290-RAGTCATCGTCGTCCTCCA
Sliv-Sco6291-FGCCGACCTCGACGAAGA
Sliv-Sco6291-RTTGTCGGTTTCACTGCTGTC
Sliv-Sco6292-FCATCGACACCAAGGTGGAC
Sliv-Sco6292-RTGACCCCGACGATGTACC
Sliv-Sco6293-FGACTACGGCGTGCTCTTCAT
Sliv-Sco6293-RCTCGGTGACCTCGACCAT
Bc0905-FCTTCGCTGACGGACAAGTAGA
Bc0905-RTGTACCGCTGTTACGGACAA
Bc0906-FACTACGAACGCAACCACACC
Bc0906-RCGGAACTTGAAGGTCTCCTGT
Bc2832-FTACCAGGCTTTGGTCCTGAA
Bc2832-RATTTGCCGCCAAGCTCTAAC
Bc2833-FGGATGGGTTTCAGTAGCAGGA
Bc2833-RCCTAGTCTTGGATAGCGAGAAGG
Bc2834-FAGGTGCGTATTCGCCAGAAA
Bc2834-RCCTGGCGAACGTACGATAAA
Bc2835-FAACAGACCCGTGTCATCCTG
Bc2835-RACTAAGCCAGCCGGTGTATCT
Bc2836-FCCTTGCATTCTCGCTTCTGT
Bc2836-RAATCTTAGGAGCCCACACACC
Atu3947-FTCCGGCCAAGTATGTGAAAG
Atu3947-RCTATAGCCGTTCGCAGCAAG
Atu3948-FATTTCGCCCGTGATCTGTC
Atu3948-RCGGCATCCACAATAATCCAG
Atu3949-FGCGAACAGGCTGAAGAGATG
Atu3949-RCGGCGGTAATTCCTGTTTG
Atu3950-FGCTGCCGAACATATCAAGGT
Atu3950-RGACCTTCGCGGTTATCTGGT
Atu3951-FTGACGGACTCCAGCCTTATC
Atu3951-RATGTAACATCGGCGTGGTCT
Atu3952-FGATATCGTCAAGGGCGGTTT
Atu3952-RACGCAGAGCCTTCATGTGTT
Atu3953-FCAACGTCGCCAGTTACCTTC
Atu3953-RGGCTGAGATCAACGACATCC
Atu3958-FGGCGGCTGATACACATCTTC
Atu3958-RAAAGTTGGTGCTTCGTCAGG
Atu3959-FCATTCCTGACACGATCCACA
Atu3959-RCAGCATCAGCAAAGGGAAGT
Atu3960-FGAATGTCGTCGCCATCAAG
Atu3960-RTCGTAGAGTGCCACATGCTC
Atu3961-FTTCGGCACTTCTTTCTGGTC
Atu3961-RGCTCGCCTGCAGATAAACA
Atu4675-FTTCCTGTTATCGTCGGCACT
Atu4675-RGCCTTGAAGTGAGCCTTCTG
Atu4676-FACGGCTATCGTGAAGGTCAA
Atu4676-RGAATAGCTCGGGCACATCAC
Atu4682-FTCCTCAGAAAGACCGACACC
Atu4682-RGTGAATGTGCCGCAGGTAA
Atu4684-FCCTCGGCAAACTCAAGGTC
Atu4684-RGCGAAGAGGCAGAAGGAAA
Atu4691-FAAGGGCGATATGGGTCTTTC
Atu4691-RGAGCTCTTCGATGCTGTCGT

qRT-PCRs were carried out in 96-well plates using the Roche LightCycler 480 II instrument with the LightCycler 480 SYBR Green I Master Mix (Roche) per the manufacturer's instructions. Each 10-µl reaction contained 1 µM of each primer, 5 µl of SYBR Green I Master Mix, and an appropriate dilution of cDNA. Reactions were run as follows: one cycle at 95°C for 5 min, 45 cycles at 95°C for 10 s, 50°C for 10 s, 72°C for 10 s, and a final dissociation program at 95°C for 15 s, 60°C for 1 min, and 95°C for 15 s. Minus-RT controls were performed to verify the absence of genomic DNA in each RNA sample for each gene target analyzed. Gene expression data were expressed as crossing threshold (CT) values. Data were analyzed by the 2-??CT (Livak) method (Livak and Schmittgen, 2001), using the 16S rRNA gene as a reference. Each qRT-PCR was performed in triplicate, and fold-changes are the averages of at least three biological replicates.

Data deposition

Request a detailed protocol

The atomic coordinates and structure factors for ‘4R-hydroxyproline 2-epimerases’ (4HypE) from Pseudomonas putida F1 (citrate-liganded, PDBID:4JBD; sulfate-liganded, PDBID:4JD7), Chromohalobacter salexigens DSM 3043 (apo, PDBID:4JCI), Xanthomonas campestris (phosphate-liganded, PDBID:4JUU), Burkholderia multivorans (phosphate-liganded, PDBID:4K7X), Pseudomonas fluorescens Pf-5 (pyrrole 2-carboxylate-liganded, PDBID:4J9W; trans-4-hydroxy-L-proline-liganded, PDBID:4J9X), Ochrobacterrium anthropic (apo, PDBID:4K8L), and Agrobacterium vitis S4 (trans-4-hydroxy-L-proline-liganded, PDBID:4LB0) and ‘trans-3-hydroxy-L-proline dehydratase’ (t3HypD) from Agrobacterium vitis S4 (pyrrole 2-carboxylate-liganded, PDBID:4K7G) have been deposited in the Protein Data Bank, www.pdb.org.

UniProt accession IDS

Request a detailed protocol

This manuscript describes functional characterization of proteins with the following UniProt accession IDs: A0NXQ7, A0NXQ9, A1B0W2, A1B195, A1B196, A1B7P4, A1BBM5, A1U2K1, A3M4A9, A3PPJ8, A3QFI1, A3QH73, A3S939, A3SU01, A5VZY6, A6WW16, A6WXX7, A8H392, A9AKG8, A9AKH1, A9AL52, A9ALD3, A9AQW9, A9CFU8, A9CFU9, A9CFV0, A9CFV4, A9CFW8, A9CGZ4, A9CGZ5, A9CGZ9, A9CH01, A9CH04, A9CKB4, B0VB44, B1KJ76, B3D6W2, B4EHE6, B9J8G8, B9JHU6, B9JQV3, B9K4G4, B9R4E3, C5ZMD2, D2AV87, D2QN44, D5SQS4, D6EJK6, D6EJK7, D6EJK8, D6EJK9, D6EJL0, Q0B950, Q0B953, Q0B9R9, Q0B9S2, Q16D96, Q1QBF3, Q1QU06, Q1QV19, Q2KD13, Q2T3J4, Q2T596, Q3IWG2, Q3IZJ8, Q3JFG0, Q3JHA9, Q485R8, Q4KAT3, Q4KGT8, Q4KGU2, Q5LKW3, Q5LLV0, Q63FA5, Q6HMS8, Q6HMS9, Q73CR9, Q73CS0, Q7CFV0, Q7CTP1, Q7CTP2, Q7CTP3, Q7CTP4, Q7CTQ2, Q7CTQ3, Q7CTQ5, Q7CVK1, Q7NU77, Q81CD6, Q81CD7, Q81CD8, Q81CD9, Q81CE0, Q81HB0, Q81HB1, Q8FYS0, Q8P833, Q8YFD6, Q92WR9, Q92WS1, Q9I476, Q9I489, and Q9I492.

Data availability

The following data sets were generated
The following previously published data sets were used

References

    1. Emsley P
    2. Cowtan K
    (2004) Coot: model-building tools for molecular graphics
    Acta Crystallographica Section D, Biological Crystallography 60:2126–2132.
    https://doi.org/10.1107/S0907444904019158
    1. Evans P
    (2006) Scaling and assessment of data quality
    Acta Crystallographica Section D, Biological Crystallography 62:72–82.
    https://doi.org/10.1107/S0907444905036693
    1. Hopwood DA
    (1967)
    Genetic analysis and genome structure in Streptomyces coelicolor
    Bacteriological Reviews 31:373–403.
    1. Koo PH
    2. Adams E
    (1974)
    Alpha-ketoglutaric semialdehyde dehydrogenase of Pseudomonas. Properties of the separately induced isoenzymes
    The Journal of Biological Chemistry 249:1704–1716.
    1. Li C
    2. Lu CD
    (2009) Arginine racemization by coupled catabolic and anabolic dehydrogenases
    Proceedings of the National Academy of Sciences of the United States of America 106:906–911.
    https://doi.org/10.1073/pnas.0808269106
    1. Liu Y
    2. Gorodichtchenskaia E
    3. Skarina T
    4. Yang C
    5. Joachimiak A
    6. Edwards A
    7. Pai EF
    8. Savchenko A
    (2005)
    PDB ID: 2AZP. Midwest Center for structural genomics (MCSG). Crystal Structure of PA1268 Solved by Sulfur SAD
    PDB ID: 2AZP. Midwest Center for structural genomics (MCSG). Crystal Structure of PA1268 Solved by Sulfur SAD.
    1. Reina-San-Martín B
    2. Degrave W
    3. Rougeot C
    4. Cosson A
    5. Chamond N
    6. Cordeiro-Da-Silva A
    7. Arala-Chaves M
    8. Coutinho A
    9. Minoprio P
    (2000)
    A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase
    Nature Medicine 6:890–897.
    1. Singh RM
    2. Adams E
    (1965)
    Enzymatic deamination of delta-1-pyrroline-4-hydroxy-2-carboxylate to 2,5-dioxovalerate (alpha-ketoglutaric semialdehyde)
    The Journal of Biological Chemistry 240:4344–4351.
    1. Spizizen J
    (1958) Transformation of biochemically deficient strains of bacillus subtilis by deoxyribonucleate
    Proceedings of the National Academy of Sciences of the United States of America 44:1072–1078.
    https://doi.org/10.1073/pnas.44.10.1072
    1. Stadtman TC
    2. Elliott P
    (1957)
    Studies on the enzymic reduction of amino acids. II. Purification and properties of D-proline reductase and a proline racemase from Clostridium sticklandii
    The Journal of Biological Chemistry 228:983–997.

Article and author information

Author details

  1. Suwen Zhao

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Contribution
    SZ, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Ayano Sakai, Xinshuai Zhang, Matthew W Vetting and Ritesh Kumar
    Competing interests
    The authors declare that no competing interests exist.

  2. Ayano Sakai

    Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, United States
    Contribution
    AS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Suwen Zhao, Xinshuai Zhang, Matthew W Vetting and Ritesh Kumar
    Competing interests
    The authors declare that no competing interests exist.

  3. Xinshuai Zhang

    Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, United States
    Contribution
    XZ, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Suwen Zhao, Ayano Sakai, Matthew W Vetting and Ritesh Kumar
    Competing interests
    The authors declare that no competing interests exist.

  4. Matthew W Vetting

    Department of Biochemistry, Albert Einstein College of Medicine, New York, United States
    Contribution
    MWV, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Suwen Zhao, Ayano Sakai, Xinshuai Zhang and Ritesh Kumar
    Competing interests
    The authors declare that no competing interests exist.

  5. Ritesh Kumar

    Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, United States
    Contribution
    RK, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Contributed equally with
    Suwen Zhao, Ayano Sakai, Xinshuai Zhang and Matthew W Vetting
    Competing interests
    The authors declare that no competing interests exist.

  6. Brandan Hillerich

    Department of Biochemistry, Albert Einstein College of Medicine, New York, United States
    Contribution
    BH, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

  7. Brian San Francisco

    Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, United States
    Contribution
    BSF, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

  8. Jose Solbiati

    Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, United States
    Contribution
    JS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

  9. Adam Steves

    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States
    Contribution
    AS, Conception and design
    Competing interests
    The authors declare that no competing interests exist.

  10. Shoshana Brown

    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States
    Contribution
    SB, Conception and design
    Competing interests
    The authors declare that no competing interests exist.

  11. Eyal Akiva

    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States
    Contribution
    EA, Conception and design
    Competing interests
    The authors declare that no competing interests exist.

  12. Alan Barber

    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States
    Contribution
    AB, Conception and design
    Competing interests
    The authors declare that no competing interests exist.

  13. Ronald D Seidel

    Department of Biochemistry, Albert Einstein College of Medicine, New York, United States
    Contribution
    RDS, Conception and design, Acquisition of data, Analysis and interpretation of data, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

  14. Patricia C Babbitt

    Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States
    Contribution
    PCB, Conception and design, Drafting or revising the article
    Competing interests
    The authors declare that no competing interests exist.

  15. Steven C Almo

    Department of Biochemistry, Albert Einstein College of Medicine, New York, United States
    Contribution
    SCA, Conception and design, Analysis and interpretation of data, Drafting or revising the article
    For correspondence
    steve.almo@einstein.yu.edu
    Competing interests
    The authors declare that no competing interests exist.

  16. John A Gerlt

    1. Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, United States
    2. Department of Biochemistry, University of Illinois at Urbana-Champaign, Urbana, United States
    3. Department of Chemistry, University of Illinois at Urbana-Champaign, Urbana, United States
    Contribution
    JAG, Conception and design, Analysis and interpretation of data, Drafting or revising the article
    For correspondence
    j-gerlt@illinois.edu
    Competing interests
    The authors declare that no competing interests exist.

  17. Matthew P Jacobson

    Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, United States
    Contribution
    MPJ, Conception and design, Analysis and interpretation of data, Drafting or revising the article
    For correspondence
    matt@cgl.ucsf.edu
    Competing interests
    The authors declare that no competing interests exist.

Funding

National Institute of General Medical Sciences (P01GM071790)

  • Patricia C Babbitt
  • Steven C Almo
  • John A Gerlt
  • Matthew P Jacobson

National Institute of General Medical Sciences (U54GM093342)

  • Patricia C Babbitt
  • Steven C Almo
  • John A Gerlt
  • Matthew P Jacobson

National Institute of General Medical Sciences (U54GM074945)

  • Steven C Almo

National Institute of General Medical Sciences (U54GM094662)

  • Steven C Almo

National Institute of General Medical Sciences (P41GM103311)

  • Steven C Almo

Argonne National Laboratory, Office of Science (DE-AC02-06CH11357)

  • Steven C Almo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This research was supported by a program project grant and three cooperative agreements from the US National Institutes of Health (P01GM071790, U54GM093342, U54GM074945, and U54GM094662). Molecular graphics and analyses were performed with the UCSF Chimera package; Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). We thank Dr John ‘Scooter’ Morris for help in using Cytoscape for visualizing complex sequence networks. We gratefully acknowledge Rafael Toro and Rahul Bohsle for maintenance of the AECOM crystallization facility and assistance and advice on crystallization experiment assembly. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.

Copyright

© 2014, Zhao et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,906
    views
  • 726
    downloads
  • 83
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Suwen Zhao
  2. Ayano Sakai
  3. Xinshuai Zhang
  4. Matthew W Vetting
  5. Ritesh Kumar
  6. Brandan Hillerich
  7. Brian San Francisco
  8. Jose Solbiati
  9. Adam Steves
  10. Shoshana Brown
  11. Eyal Akiva
  12. Alan Barber
  13. Ronald D Seidel
  14. Patricia C Babbitt
  15. Steven C Almo
  16. John A Gerlt
  17. Matthew P Jacobson
(2014)
Prediction and characterization of enzymatic activities guided by sequence similarity and genome neighborhood networks
eLife 3:e03275.
https://doi.org/10.7554/eLife.03275

Share this article

https://doi.org/10.7554/eLife.03275

Categories and tags

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    Malaria parasites require a divergent heme oxygenase for apicoplast gene expression and biogenesis

    Amanda Mixon Blackwell, Yasaman Jami-Alahmadi ... Paul A Sigala
    Research Article

    Malaria parasites have evolved unusual metabolic adaptations that specialize them for growth within heme-rich human erythrocytes. During blood-stage infection, Plasmodium falciparum parasites internalize and digest abundant host hemoglobin within the digestive vacuole. This massive catabolic process generates copious free heme, most of which is biomineralized into inert hemozoin. Parasites also express a divergent heme oxygenase (HO)-like protein (PfHO) that lacks key active-site residues and has lost canonical HO activity. The cellular role of this unusual protein that underpins its retention by parasites has been unknown. To unravel PfHO function, we first determined a 2.8 Å-resolution X-ray structure that revealed a highly α-helical fold indicative of distant HO homology. Localization studies unveiled PfHO targeting to the apicoplast organelle, where it is imported and undergoes N-terminal processing but retains most of the electropositive transit peptide. We observed that conditional knockdown of PfHO was lethal to parasites, which died from defective apicoplast biogenesis and impaired isoprenoid-precursor synthesis. Complementation and molecular-interaction studies revealed an essential role for the electropositive N-terminus of PfHO, which selectively associates with the apicoplast genome and enzymes involved in nucleic acid metabolism and gene expression. PfHO knockdown resulted in a specific deficiency in levels of apicoplast-encoded RNA but not DNA. These studies reveal an essential function for PfHO in apicoplast maintenance and suggest that Plasmodium repurposed the conserved HO scaffold from its canonical heme-degrading function in the ancestral chloroplast to fulfill a critical adaptive role in organelle gene expression.

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    Endogenous oligomer formation underlies DVL2 condensates and promotes Wnt/β-catenin signaling

    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.

    1. Biochemistry and Chemical Biology
    2. Physics of Living Systems

    Reversing protonation of weakly basic drugs greatly enhances intracellular diffusion and decreases lysosomal sequestration

    Debabrata Dey, Shir Marciano ... Gideon Schreiber
    Research Article

    For drugs to be active they have to reach their targets. Within cells this requires crossing the cell membrane, and then free diffusion, distribution, and availability. Here, we explored the in-cell diffusion rates and distribution of a series of small molecular fluorescent drugs, in comparison to proteins, by microscopy and fluorescence recovery after photobleaching (FRAP). While all proteins diffused freely, we found a strong correlation between pKa and the intracellular diffusion and distribution of small molecule drugs. Weakly basic, small-molecule drugs displayed lower fractional recovery after photobleaching and 10- to-20-fold slower diffusion rates in cells than in aqueous solutions. As, more than half of pharmaceutical drugs are weakly basic, they, are protonated in the cell cytoplasm. Protonation, facilitates the formation of membrane impermeable ionic form of the weak base small molecules. This results in ion trapping, further reducing diffusion rates of weakly basic small molecule drugs under macromolecular crowding conditions where other nonspecific interactions become more relevant and dominant. Our imaging studies showed that acidic organelles, particularly the lysosome, captured these molecules. Surprisingly, blocking lysosomal import only slightly increased diffusion rates and fractional recovery. Conversely, blocking protonation by N-acetylated analogues, greatly enhanced their diffusion and fractional recovery after FRAP. Based on these results, N-acetylation of small molecule drugs may improve the intracellular availability and distribution of weakly basic, small molecule drugs within cells.